FDA Limits Use of J&J COVID Vaccine Due to Blood Clot Risk
THURSDAY, May 5, 2022 (HealthDay News) — Citing the accumulated data on a raised risk for a type of dangerous blood clot, the U.S. Food and Drug Administration on Thursday greatly restricted the recommended use of the Johnson & Johnson COVID-19 vaccine. With safer two-dose vaccines such as Pfizer andContinue Reading